Tachykinin regulation of cholinergic transmission in the limbic/prefrontal territory of the rat dorsal striatum: Implication of new neurokinine 1-sensitive receptor binding site and interaction with enkephalin/mu opioid receptor transmission

Journal of Neurochemistry

Volumn 103, Issue 6, 2007, Pages 2153-2163

  Pérez, Sylvie ^b   Tierney, Adrienne ^b   Deniau, Jean Michel ^b   Kemel, Marie Louise ^a  

^a INSERM   (France)

^b NONE

Author keywords

Acetylcholine; Mu opioid receptor; Striatum; Tachykinin; Tachykinin NK 1 receptor subtypes

Indexed keywords

ENKEPHALIN; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ A; NEUROPEPTIDE K; SUBSTANCE P [6-11]; TACHYKININ; VOFOPITANT;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CHOLINERGIC TRANSMISSION; CIRCADIAN RHYTHM; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIMBIC CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; RECEPTOR BINDING;

ACETYLCHOLINE; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CHOLINERGIC FIBERS; CIRCADIAN RHYTHM; ENKEPHALINS; LIMBIC SYSTEM; MALE; MORPHOLINES; NARCOTIC ANTAGONISTS; NEOSTRIATUM; NEURAL PATHWAYS; ORGAN CULTURE TECHNIQUES; PIPERIDINES; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; RECEPTORS, OPIOID, MU; SYNAPTIC TRANSMISSION; TACHYKININS;

RATTUS;

EID: 36448935687     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04944.x     Document Type: Article

References (57)

1. 1 receptors. J. Pharmac. Exp. Ther. 269, 1144 1151.
2. Aosaki T. Kawaguchi Y. (1996) Actions of substance P on rat neostriatal neurons in vitro. J. Neurosci. 16, 5141 5153.
3. Aosaki T., Tsubokawa H., Ishida A., Watanabe K., Graybiel A. M. Kimura M. (1994) Responses of tonically active neurones in the primate's striatum undergo systematic changes during behavioral sensorimotor conditioning. J. Neurosci. 14, 3969 3984.
4. Apicella P. (2002) Tonically active neurons in the primate striatum and their role in the processing of information about motivationally relevant events. Eur. J. Neurosci. 16, 2017 2026.
5. Beaujouan J. C., Saffroy M., Torrens Y. Glowinski J. (2000) Different subtypes of tachykinin receptor binding sites are present in the rat brain. J. Neurochem. 75, 1015 1026.
6. Beaujouan J. C., Torrens Y., Saffroy M., Kemel M. L. Glowinski J. (2004) A 25 year adventure in the field of tachykinins.Peptides. Peptides 25, 339 357.
7. Berendse H. W., Galis-de Graaf Y. Groenewegen H. J. (1992) Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J. Comp. Neurol. 316, 314 347.
8. 3H]-acetylcholine in striatal compartments of the rat: regulatory roles of dopamine and GABA. Neuroscience 81, 113 127.
9. 2 (SR48968) tachykinin receptor antagonists of the N-Methyl-D-Aspartate-evoked release of acetylcholine in striosomes and matrix of the rat striatum. Neuroscience 85, 1025 1036.
10. Bolam J. P. Bennett B. D. (1995) Microcircuitry of the neostriatum, in Molecular and cellular mechanisms of neostriatal function (Ariano M. A. Surmeier D. J., eds pp. 1 19. Landes Company, Austin, Texas.
11. Bradshaw J. L. Sheppard D. M. (2000) The neurodevelopmental frontostriatal disorders: evolutionary adaptiveness and anomalous lateralization. Brain Lang. 73, 297 320.
12. Carlsson M. L. (2001) On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 5 26.
13. Daugé V., Mauborgne A., Cesselin F., Fournié-Zaluski M. C. Roques B. P. (1996) The dual peptidase inhibitor RB101 induces a long-lasting increase in the extracellular level of Met-enkephalin-like material in the nucleus accumbens of freely moving rats. J. Neurochem. 67, 1301 1308.
14. Day J., Damsma G. Fibiger H. C. (1991) Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study. Pharmacol. Biochem. Behav. 38, 723 729.
15. De Prado B. M., Reiter R. J. Mora F. (2003) Perfusion of melatonin into the prefrontal cortex disrupts the circadian rhythm of acetylcholine but not of locomotor activity. J. Pineal Res. 35, 283 287.
16. Deniau J. M. Thierry A. M. (1997) Anatomical segregation of information processing in the rat substantia nigra pars reticulata, in Advances in Neurology (Obeso J. A., DeLong M. R., Ohye C. Marsden C. D., eds pp. 83 96. Lippincott-Raven Publishers, Philadelphia, 74.
17. Desban M., Kemel M. L., Glowinski J. Gauchy C. (1993) Spatial organization of patch and matrix compartments in the rat striatum. Neuroscience 57, 661 671.
18. Dubois B. Pillon B. (1997) Cognitive deficits in Parkinson's disease. J. Neurol. 244, 2 8.
19. Ferro E. S., Sucupira M., Marques N., Camargo A. C. Menna-Barreto L. (1992) Circadian rhythm of the endopeptidase 22.19 (EC 3.4.22.19) in the rat brain. Chronobiol. Int. 9, 243 249.
20. Gerfen C. R. (1991) Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res. 556, 165 170.
21. Gerfen C. R. Wilson C. J. (1996) The basal ganglia, in Handbook of Chemical Neuroanatomy, Integrated systems of the CNS, Part III, vol 12 (Swanson L. W., Bjorklund A. Hokfelt T, eds pp. 371 468. Elsevier, Amsterdam.
22. Gillman M. A. Sandyk R. (1986) The endogenous opioid system in Gilles de la Tourette syndrome. Med. Hypotheses 19, 371 378.
23. Glowinski J. (1995) The "septide-sensitive" tachykinin receptor: still an enigmatic story. Trends Pharmacol. Sci. 16, 365 367.
24. Graybiel A. M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244 254.
25. Graybiel A. M. Rauch S. L. (2000) Toward a neurobiology of obsessive-compulsive disorder. Neuron 28, 343 347.
26. Graybiel A. M., Aosaki T., Flaherty A. W. Kimura M. (1994) The basal ganglia and adaptative motor control. Science 265, 1826 1831.
27. Holst B., Hastrup H., Raffetseder U., Martini L. Schwartz T. W. (2001) Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis. J. Biol. Chem. 276, 19793 19799.
28. Izzo P. N. Bolam J. P. (1988) Cholinergic synaptic input to different parts of spiny striatonigral neurons in the rat. J. Comp. Neurol. 269, 219 234.
29. 3H]-acetylcholine in the limbic territory of the rat striatum in vitro: diurnal variations and implication of a dopamine link. Neuroscience 123, 733 742.
30. Jabourian M., Venance L., Bourgoin S., Ozon S., Perez S., Godeheu G., Glowinski J. Kemel M. L. (2005) Functional mu opioid receptors are expressed in cholinergic interneurons of the rat dorsal striatum: territorial specificity and diurnal variation. Eur. J. Neurosci. 21, 3301 3309.
31. Jabourian M., Perez S., Ezan P., Glowinski J., Deniau J. M. Kemel M. L. (2007) Impact of 6-hydroxydopamine lesion or cocaine exposure on mu opioid receptor expression and regulation of cholinergic transmission in the limbic/prefrontal territory of the rat dorsal striatum. Eur. J. Neurosci. 25, 1546 1556.
32. Jakab R. L. Goldman-Rakic P. (1996) Presynaptic and postsynaptic subcellular localization of substance P receptor immunoreactivity in the neostriatum of the rat and Rhesus monkey (Macaca mulatta). J. Comp. Neurol. 369, 125 136.
33. Jakab R. L., Hazrati L. Goldman-Rakic P. (1996) Distribution and neurochemical character of substance P receptor (SPR)-immunoreactive striatal neurons of the macaque monkey: accumulation of SP fibers and SPR neurons and dendrites in "striocapsules" encercling striosomes. J. Comp. Neurol. 369, 137 149.
34. Kaneko T., Shigemoto R., Nakanishi S. Misumo N. (1993) Subtance P receptor-immunoreactive neurons in the rat neostriatum are segregated into somatostatinergic and cholinergic aspiny neurons. Brain Res. 631, 297 303.
35. Kawaguchi Y. (1992) Large aspiny cells in the matrix of the rat neostriatum in vitro: physiological identification, relation to the compartments and excitatory postsynaptic currents. J. Neurophysiol. 67, 1669 1682.
36. Kemel M. L., Desban M., Glowinski J. Gauchy C. (1989) Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus. Proc. Natl. Acad. Sci. USA 86, 9006 9010.
37. Kemel M. L., Pérez S., Godeheu G., Soubrié P. Glowinski J. (2002) Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum. J. Neurosci. 22, 1929 1936.
38. Kemel M. L., Perez S., Beaujouan J. C., Jabourian M., Soubrié P. Glowinski J. (2003) The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum. J. Neurochem. 87, 487 496.
39. Krebs M. O., Trovero F., Desban M., Gauchy C., Glowinski J. Kemel M. L. (1991) Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix- enriched areas of the rat striatum. J. Neurosci. 11, 1256 1262.
40. Lendvai B., Sandor N. T. Sandor A. (1993) Influence of selective opiate antagonists on striatal acetylcholine and dopamine release. Acta Physiol. Hung. 81, 19 28.
41. Li J. L., Wang D., Kaneko T., Shigemoto R., Nomura S. Mizuno N. (2000) Relationship between neurokinin-1 receptor and substance P in the striatum: light and electron microscopic immunohistochemical study in the rat. J. Comp. Neurol. 418, 156 163.
42. Lundberg S., Carlsson A., Norfeldt P. Carlsson M. L. (2004) Nicotine treatment of obsessive-compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 1195 1199.
43. Maggi C. A. Schwartz T. W. (1997) The dual nature of the tachykinin NK1 receptor. Trends Pharmacol. Sci. 18, 351 354.
44. Mangold D. L., Peyrot M., Giggey P. Wand G. S. (2000) Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism. Neuropsychopharmacology 22, 595 607.
45. Nieoullon A. (2002) Dopamine and the regulation of cognition and attention. Prog. Neurobiol. 67, 53 83.
46. Paxinos G. Watson C. (1986) The rat brain in stereotaxic coordinates. Academic Press, Australia.
47. Sagan S., Karoyan P., Chassing G. Lavielle S. (1999) Further delineation of the two binding sites (R*(n)) associated with tachykinin neurokinin-1 receptors using [3-Prolinomethionine(11)]SP analogues. J. Biol. Chem. 274, 23770 23776.
48. 3H-acetylcholine release evoked by excitatory amino acids. Nature 297, 422 424.
49. Shults C. W., Quirion R., Chronwall B., Chase T. N. O'Donohue T. L. (1984) A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system. Peptides 5, 1097 1128.
50. Steinberg R., Souilhac J., Rodier D., Alonso X., Emonds-Alt X., Le Fur G. Soubrié P. (1998) Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation. Neuroscience 84, 511 518.
51. Steinberg R., Alonso R., Rouquier L. et al. (2002) SSR240600 [(R)- 2-(1-{2-[3,5-Bis(trifluotomethyl)-phenyl]acetyl}-2-(3,4-dichlorophenyl) -2-morpholinyl]ethyl}-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: II Neurochemical and behavioral characterization. JPET 303, 1180 1188.
52. Tepper J. M. Bolam J. P. (2004) Functional diversity and specificity of neostriatal interneurons. Curr. Opin. Neurobiol. 14, 685 692.
53. Volkow N. D., Fowler J. S., Wang G. J. Swanson J. M. (2004) Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 6, 557 569.
54. Wang H., Moriwaki A., Wang J. B., Uhl G. R. Pickel V. M. (1996) Ultrastructural immunocytochemical localization of mu opioid receptors and Leu5-enkephalin in the patch compartment of the rat caudate-putamen nucleus. J. Comp. Neurol. 375, 659 674.
55. Wang Z., Kai L., Day M., Ronesi J., Yin H. H., Ding J., Tkatch T., Lovinger D. M. Surmeier D.J. (2006) Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50, 443 452.
56. Westerink B. H. (1995) Brain microdialysis and its application for the study of animal behaviour. Behav. Brain Res. 70, 103 124.
57. Zhu J., Luo L.Y., Li J.G., Chen C. Liu-Chen L.Y. (1997) Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. J. Pharmacol. Exp. Ther. 282, 676 684.